Ontology highlight
ABSTRACT: Background
Evidence regarding potential adverse neuropsychiatric effects of efavirenz is conflicting, and data from sub-Saharan Africa, where 70% of persons living with HIV (PLHIV) reside and efavirenz is used as first-line therapy, are limited.Objective
To estimate associations between efavirenz use and depression and suicidal ideation among PLHIV in Uganda.Design
Prospective observational cohort study. (ClinicalTrials.gov: NCT01596322).Setting
Mbarara, Uganda.Participants
Adult PLHIV enrolled at the start of antiretroviral therapy (ART) and observed every 3 to 4 months from 2005 to 2015.Measurements
The exposure of interest was time-varying efavirenz use, defined as use during the 7 days and in 60 or more of the 90 days before a study visit
SUBMITTER: Chang JL
PROVIDER: S-EPMC6475600 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature